What was filed
Neogen Chemicals told the exchanges that its Fund-Raising Committee, meeting on September 10, 2026, approved the opening of a qualified institutions placement (QIP) of equity shares and authorised the issue to open the same day. The committee also adopted the preliminary placement document and the application form to be sent to eligible qualified institutional buyers.
The placement rests on approvals already in place: the Board sanctioned the fund-raise on July 24, 2026, and shareholders passed the enabling special resolution on August 21, 2026, per the filing.
Pricing and the discount option
The committee fixed September 10, 2026 as the 'Relevant Date' and set the floor price under the SEBI ICDR pricing formula. The company noted it may, at its discretion, offer a discount on that floor price, and said the final issue price will be determined in consultation with the appointed lead managers.
The filing does not state the number of shares to be issued or the amount the company intends to raise; those remain to be determined.
Why it matters to a holder
A QIP issues fresh equity to institutional buyers, raising capital for the company while increasing the share count. Because the issue size and final price were not disclosed in this filing, the extent of any dilution cannot yet be quantified from the document. The company said it will file the preliminary placement document with BSE and NSE on the same date and make it available on its website.